A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)
Clinical trial NCT04153565 · COMPLETED
Trial details
- NCT number
- NCT04153565
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2022-09-21
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.